Article Information
History
- September 23, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Cristian Villanueva1,
- Ibeth Neyra1,
- Arturo Sagastegui1,
- Ausberto Chunga1,
- Martin Oyanguren1,
- Martina Guillermo-Roman2,
- Suly Soto-Ordoñez2,
- Jorge L. Maguiña2,
- Yamilee Hurtado-Roca2,
- Percy Soto-Becerra2 and
- Roger V. Araujo-Castillo2,*
- 1Hospital Nacional Edgardo Rebagliati Martins, EsSalud, Lima, Perú
- 2Instituto de Evaluación de Tecnologías en Salud e Investigación – IETSI, EsSalud, Lima, Perú
- ↵*Corresponding:
Roger V. Araujo-Castillo, MD, Address: Cápac Yupanqui 1400 - Jesus María, Lima 11, Perú, Phone: (511) 748 1111 ext 2143, E-mail: araujocaroger{at}gmail.com
Posted September 23, 2022.
Efficacy and safety of convalescent plasma versus standard care in hospitalized patients with COVID-19 from the Peruvian Social Security Health System: open-label, randomized, controlled clinical trial
